34 results on '"Psoriatic arthritis -- Care and treatment"'
Search Results
2. TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade
3. Treatment recommendations for psoriatic arthritis
4. A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tissue
5. Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
6. A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis
7. Efficacy and tolerability of anti-tumour necrosis factor in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register
8. The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study
9. Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis
10. Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial
11. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment
12. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany
13. The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year
14. Infliximab improves health related quality of life and physical function in patients with psoriatic arthritis
15. Psoriatic arthritis and psoriasis: role of patient advocacy organisations in the twenty first century
16. Science of assessment
17. Psoriatic arthritis: epidemiology, clinical features, course, and outcome
18. p53 expression in rheumatoid and psoriatic arthritis synovial tissue and association with joint damage
19. TNF alfa therapy in psoriatic arthritis and psoriasis
20. Randomised placebo controlled trial og delipidated, deglycolipidated Mycobacterium vaccae as immunotherapy for psoriatic arthritis
21. Psoriatic arthritis: how to deal with it in an examination
22. Hepatoprotective effect of tumour necrosis factor (alpha) blockade in psoriatic arthritis: a cross-sectional study
23. Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun)
24. Sustained response to long-term biologics and switching in psoriatic arthritis: results from real life experience
25. Synovial immunopathological changes associated with successful abatacept therapy in a case of severe refractory psoriatic arthritis
26. Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis
27. Lipoma arborescens co-existing with psoriatic arthritis releases tumour necrosis factor alpha and matrix metalloproteinase 3
28. Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis
29. Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis
30. Successful treatment of psoriatic arthritis with rituximab
31. On the applicability of the CASPAR criteria in psoriatic arthritis
32. Anti-tumour necrosis factor agents and lipid profile: a class effect?
33. Infliximab in refractory psoriatic arthritis with severe psoriasis: a 2-year experience
34. Amelioration of severe psoriasis with psoriatic arthritis for 20 years after allogeneic haematopoietic stem cell transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.